NEOGENOMICS INC — Director's Dealing 2016

Jul 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-07-28

Reporting Person: Johnson Kevin C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-28	Restricted Stock	$	A	5072	Acquired	2017-03-31	Common Stock (5072)	Direct
2016-07-28	Stock Option (Right to Buy)	$9.11	A	8333	Acquired	2021-07-28	Common Stock (8333)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	117754	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock	$	2017-03-31	Common Stock (2150)	2150	Direct
Stock Option (Right to Buy)	$4.78	2020-05-06	Common Stock (10000)	17222	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F2: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017.

F3: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017.

F4: On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F5: On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.